Login / Signup

Phase II study of durvalumab (MEDI 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study (LOGIK 2003).

Hidenobu IshiiKoichi AzumaTakayuki ShimoseHiroshige YoshiokaTakayasu KurataNaoki ShinguMasaki OkamotoYosuke KawashimaIsamu Okamoto
Published in: Thoracic cancer (2022)
The present study was designed to evaluate the safety of durvalumab plus carboplatin and etoposide in elderly patients with ES-SCLC.
Keyphrases
  • phase ii study
  • small cell lung cancer
  • open label
  • study protocol
  • randomized controlled trial
  • locally advanced
  • squamous cell carcinoma
  • middle aged
  • community dwelling
  • phase iii
  • brain metastases